U.S. Markets closed

Accelr8 announces results of two studies, acceptance to show blood study

Accelr8 Technology announced results of two studies that it presented at the 112th annual General Meeting of the American Society for Microbiology. The first study used the company’s BACcel rapid automated diagnostic system with positive blood cultures to detect a major, complex multi-drug resistance expression type known as “ESBL.” The system’s 3-hour results showed the benefits of the platform decreasing time to result by 1-2 days over the best standard method while maintaining 100% sensitivity and 94% specificity. The second study reported performance of the company’s rapid, fully automated specimen preparation technology. It showed that in 10 minutes or less, the BAC-Xtrax gel electrofiltration system concentrates live bacteria and substantially clears the sample from complex interference. Separately, Accelr8 also received notice of acceptance to present results at ICAAC 2012 for a new study entitled “Same-Day Blood Culture with Digital Microscopy.”